Tag: kidney disease and diabetes drugs
Chronic Kidney Disease and Metformin or SGLT2 Inhibitors: Dosing and Safety Guidelines 2025
Updated 2025 guidelines on using metformin and SGLT2 inhibitors safely in chronic kidney disease. Learn correct eGFR dosing thresholds, safety risks, combination therapy benefits, and what to do if your kidney function declines.
read morerecent posts
Patent exclusivity and market exclusivity are two separate legal tools that protect drug prices. Patents cover inventions; FDA exclusivity blocks generics using clinical data-even without a patent. Understanding the difference explains why some drugs stay expensive long after patents expire.
Published ON: 7 FebOsteoporosis weakens bones, increasing fracture risk. Bisphosphonate therapy slows bone loss and reduces fractures. Learn how these treatments work, their benefits, risks, and alternatives for better bone health.
Published ON: 4 FebIBS causes recurring abdominal pain, bloating, and bowel changes. Learn the real symptoms, common triggers like food and stress, and proven medication options for IBS-D, IBS-C, and mixed types - plus non-drug strategies that work.
Published ON: 2 FebDTC prescription drug ads in the U.S. drive higher demand for branded medications, often overshadowing equally effective generics. Research shows ads increase prescriptions but also lead to inappropriate requests and higher costs. Learn how advertising influences patient decisions and healthcare outcomes.
Published ON: 6 FebSubclinical hypothyroidism means elevated TSH with normal thyroid hormone levels. Should you treat it? The answer depends on your age, antibodies, symptoms, and risk factors-not just the lab number.
Published ON: 3 Feb